Medicare Enrolled
Dr. Michelle Astarita, M.D.
Hematology & Oncology · Miami, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Astarita from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Astarita?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Astarita
Dr. Michelle Astarita is a hematology & oncology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Astarita performed 1,443 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Astarita received a total of $29,808 from 93 pharmaceutical and/or device companies across 1598 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Astarita is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 37% volume in FL
$29,808 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,443
Medicare services
Top 37% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
510 | $102 | $233 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
202 | $8 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $99 | $224 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
174 | $8 | $19 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
123 | $68 | $157 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
122 | $147 | $414 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
113 | $0 | $19 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $139 | $343 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.8% high complexity
0.0% medium
92.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,808
Total received (2018-2024)
Avg $4,258/year across 7 years
Top 20% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,598
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,468
2023
$4,111
2022
$3,988
2021
$2,706
2020
$3,589
2019
$5,006
2018
$4,939
Payments by company (2024)
PFIZER INC.
$700
AstraZeneca Pharmaceuticals LP
$694
Verity Pharmaceuticals Inc.
$592
Celgene Corporation
$478
Daiichi Sankyo Inc.
$340
Astellas Pharma US Inc
$298
Janssen Biotech, Inc.
$269
Bayer Healthcare Pharmaceuticals Inc.
$262
E.R. Squibb & Sons, L.L.C.
$199
Merck Sharp & Dohme LLC
$188
Lilly USA, LLC
$143
Eisai Inc.
$138
Novartis Pharmaceuticals Corporation
$122
Takeda Pharmaceuticals U.S.A., Inc.
$92
ABBVIE INC.
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
BeiGene USA, Inc.
$83
SpringWorks Therapeutics, Inc.
$80
Incyte Corporation
$78
Mirati Therapeutics, Inc.
$73
Stemline Therapeutics Inc.
$72
SOBI, INC
$60
EMD Serono, Inc.
$56
Amneal Pharmaceuticals LLC
$52
SUN PHARMACEUTICAL INDUSTRIES INC.
$37
Coherus Biosciences Inc.
$34
RECORDATI_RARE_DISEASES_INC.
$32
180 Medical, Inc.
$27
Janssen Pharmaceuticals, Inc
$22
SERVIER PHARMACEUTICALS LLC
$20
Tempus AI, Inc
$19
BIOTISSUE HOLDINGS INC.
$18
Agios Pharmaceuticals, Inc.
$14
Top 3 companies account for 36.3% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$2,597
Novartis Pharmaceuticals Corporation
$2,546
AstraZeneca Pharmaceuticals LP
$2,538
Celgene Corporation
$2,082
Janssen Biotech, Inc.
$1,787
Merck Sharp & Dohme Corporation
$1,230
E.R. Squibb & Sons, L.L.C.
$1,179
Astellas Pharma US Inc
$1,094
Incyte Corporation
$1,061
EMD Serono, Inc.
$896
Amgen Inc.
$805
Eisai Inc.
$715
Merck Sharp & Dohme LLC
$618
Verity Pharmaceuticals Inc.
$592
Seagen Inc.
$569
Lilly USA, LLC
$446
AbbVie Inc.
$443
Bayer HealthCare Pharmaceuticals Inc.
$434
Bayer Healthcare Pharmaceuticals Inc.
$415
Boehringer Ingelheim Pharmaceuticals, Inc.
$394
GENZYME CORPORATION
$392
Daiichi Sankyo Inc.
$383
Genentech USA, Inc.
$303
Teva Pharmaceuticals USA, Inc.
$302
Myovant Sciences Inc.
$292
Rigel Pharmaceuticals, Inc.
$291
Exelixis Inc.
$272
Gilead Sciences, Inc.
$257
EISAI INC.
$227
MEDIVATION FIELD SOLUTIONS LLC
$227
Kite Pharma, Inc.
$225
Alexion Pharmaceuticals, Inc.
$209
Pharmacyclics LLC, An AbbVie Company
$208
ABBVIE INC.
$197
Takeda Pharmaceuticals U.S.A., Inc.
$183
Ipsen Biopharmaceuticals, Inc
$178
BeiGene USA, Inc.
$164
TESARO, Inc.
$163
Clovis Oncology, Inc.
$143
PharmaEssentia USA Corporation
$112
Sun Pharmaceutical Industries Inc.
$106
Janssen Pharmaceuticals, Inc
$106
SOBI, INC
$100
Mirati Therapeutics, Inc.
$96
GlaxoSmithKline, LLC.
$96
Regeneron Healthcare Solutions, Inc.
$93
MorphoSys, US Inc.
$92
Stemline Therapeutics Inc.
$90
Sumitomo Pharma America, Inc.
$89
Amneal Pharmaceuticals LLC
$88
JAZZ PHARMACEUTICALS INC.
$88
Pharmacyclics LLC, an AbbVie Company
$82
SpringWorks Therapeutics, Inc.
$80
ARRAY BIOPHARMA INC
$75
Foundation Medicine, Inc.
$73
TerSera Therapeutics LLC
$70
Seattle Genetics, Inc.
$70
SANOFI-AVENTIS U.S. LLC
$65
Organon LLC
$64
SERVIER PHARMACEUTICALS LLC
$64
Dova Pharmaceuticals
$62
Coherus Biosciences Inc.
$58
Verastem, Inc.
$58
Myriad Genetic Laboratories, Inc.
$58
Taiho Oncology, Inc.
$50
Partner Therapeutics, Inc.
$44
Teleflex LLC
$43
INSYS Therapeutics Inc
$39
Epizyme, Inc.,
$38
Jazz Pharmaceuticals Inc.
$37
SUN PHARMACEUTICAL INDUSTRIES INC.
$37
EUSA Pharma (US) LLC
$33
RECORDATI_RARE_DISEASES_INC.
$32
Karyopharm Therapeutics Inc.
$30
180 Medical, Inc.
$27
Deciphera Pharmaceuticals Inc.
$26
G1 Therapeutics, Inc.
$24
Epizyme, Inc.
$22
CSL Behring
$20
Kyowa Kirin, Inc.
$20
Tempus AI, Inc
$19
Endo Pharmaceuticals Inc.
$19
BIOTISSUE HOLDINGS INC.
$18
PORTOLA PHARMACEUTICALS, INC.
$18
Array BioPharma Inc.
$17
Sirtex Medical Inc
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Secura Bio, Inc.
$14
Apellis Pharmaceuticals, Inc.
$14
Agios Pharmaceuticals, Inc.
$14
Covidien LP
$11
Roche Products Limited
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$5
Top 3 companies account for 25.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · AVASTIN · AVEED · Abraxane · Afstyla · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BENDEKA · BESREMI · BEVYXXA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CALQUENCE · CARVYKTI · CHANTIX · CIPRODEX · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FASLODEX · FOUNDATIONONE · FOUNDATIONONE CDX · Farydak · GAUCHER-DISEASE · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · IRESSA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYRISK · NEXPLANON · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Trelstar · TruClear · ULTOMIRIS · UROLIFT · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYNDAQEL · Vectibix · Vitrakvi · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
165
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
DOCTORS HOSPITAL
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Astarita is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Astarita experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Astarita performed 510 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Astarita receive payments from pharmaceutical companies?
Yes. Dr. Astarita received a total of $29,808 from 93 companies across 1,598 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Astarita's costs compare to other hematology & oncology specialists in Miami?
Dr. Astarita's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Astarita) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Miami
Browse hematology & oncology specialists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology